Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies

Understanding the heterogeneous pathology in Alzheimer’s disease and related tauopathies is one of the most urgent and fundamental challenges facing the discovery of novel disease-modifying therapies. Through monitoring ensembles of toxic and nontoxic tau oligomers spontaneously formed in cells, our biosensor technology can identify tool compounds that modulate tau oligomer Read & Research Alzheimer’s More

Leave a Reply